Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-Label Safety And Dose Conversion/Determination Study of OROS® Oxybutynin Chloride for Urge Urinary Incontinence

NCT00269724 is registered in ClinicalTrials.gov with Alza Corporation, DE, USA as lead sponsor.

NCT NCT00269724
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00269724 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-Label Safety And Dose Conversion/Determination Study of OROS® Oxybutynin Chloride for Urge Urinary Incontinence
Lead sponsor
Alza Corporation, DE, USA
Phase
Phase 3
Overall status
Completed
Start date
March 31, 1997
Completion date
September 30, 1997
Enrollment
250
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

urinary incontinence